{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:54:29Z","timestamp":1789512869722,"version":"build-2803163510"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004633","name":"Mount Allison University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004357","name":"Procter and Gamble","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bone.2020.115518","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T21:32:20Z","timestamp":1593725540000},"page":"115518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Fifty years of bisphosphonates: What are their mechanical effects on bone?"],"prefix":"10.1016","volume":"138","author":[{"given":"David B.","family":"Burr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2020.115518_bb0005","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/jbmr.2603","article-title":"True gold or pyrite: a review of reference point indentation for assessing bone mechanical properties in vivo","volume":"30","author":"Allen","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115518_bb0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1138\/20060248","article-title":"Mineralization, microdamage, and matrix: how bisphosphonates influence material properties of bone","volume":"4","author":"Allen","year":"2007","journal-title":"BoneKEy-Osteovision"},{"key":"10.1016\/j.bone.2020.115518_bb0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bone.2010.10.159","article-title":"Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don\u2019t know","volume":"49","author":"Allen","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12018-016-9217-1","article-title":"Bone biomechanics and bone quality: effects of pharmaceutical agents used to treat osteoporosis","volume":"14","author":"Burr","year":"2016","journal-title":"Clinic Rev Bone Miner Metab"},{"key":"10.1016\/j.bone.2020.115518_bb0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11914-018-0430-3","article-title":"Recent advances in understanding bisphosphonate effects on bone mechanical properties","volume":"16","author":"Allen","year":"2018","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.bone.2020.115518_bb0030","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/8756-3282(93)90081-K","article-title":"Basic biomechanical measurements of bone: a tutorial","volume":"14","author":"Turner","year":"1993","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0035","series-title":"Skeletal Tissue Mechanics","author":"Martin","year":"2015"},{"key":"10.1016\/j.bone.2020.115518_bb0040","series-title":"Orthopaedic Basic Science. Foundations of Clinical Practice","first-page":"133","article-title":"Bone biomechanics","author":"Burr","year":"2019"},{"key":"10.1016\/j.bone.2020.115518_bb0045","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jbmr.3078","article-title":"Understanding bone strength is not enough","volume":"32","author":"Hernandez","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115518_bb0050","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jtbi.2004.07.013","article-title":"Incompatible mechanical properties in compact bone","volume":"231","author":"Currey","year":"2004","journal-title":"J Theoret Biol"},{"key":"10.1016\/j.bone.2020.115518_bb0055","doi-asserted-by":"crossref","DOI":"10.1063\/1.3693085","article-title":"A new device for performing reference point indentation without a reference probe","volume":"83","author":"Bridges","year":"2012","journal-title":"Rev. Sci. Instrum."},{"key":"10.1016\/j.bone.2020.115518_bb0060","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bone.2012.12.015","article-title":"Reference-point indentation correlates with bone toughness assess using whole-bone traditional mechanical testing","volume":"53","author":"Gallant","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0065","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/jor.1100150611","article-title":"Exercise of young thoroughbred horses increases impact strength of the third metacarpal bone","volume":"15","author":"Reilly","year":"1997","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bone.2020.115518_bb0070","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1098\/rstb.1995.0031","article-title":"Experimentally determined microcracking around a circular hole in a flat plate of bone: comparison with predicted stresses","volume":"347","author":"Zioupos","year":"1995","journal-title":"Trans R Soc Lond B Biol Scie"},{"key":"10.1016\/j.bone.2020.115518_bb0075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1138\/20100451","article-title":"Mechanisms of bone deformation and fracture","volume":"7","author":"Gupta","year":"2010","journal-title":"IBMS BoneKEy"},{"key":"10.1016\/j.bone.2020.115518_bb0080","doi-asserted-by":"crossref","first-page":"19178","DOI":"10.1073\/pnas.1201513109","article-title":"Dilatational band formation in bone","volume":"109","author":"Poundarik","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2020.115518_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a Task Force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115518_bb0090","series-title":"Mechanical Properties of Bone","author":"Evans","year":"1973"},{"key":"10.1016\/j.bone.2020.115518_bb0095","series-title":"Bones","author":"Currey","year":"2002"},{"key":"10.1016\/j.bone.2020.115518_bb0100","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0021-9290(83)90009-X","article-title":"The assessment of in vivo bone condition in humans by impact response measurement","volume":"16","author":"Wong","year":"1983","journal-title":"J. Biomech."},{"key":"10.1016\/j.bone.2020.115518_bb0105","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bonr.2016.07.004","article-title":"Technical note: recommendations for a standard procedure to assess cortical bone at the tissue-level in vivo using impact microindentation","volume":"5","author":"Diez-Perez","year":"2015","journal-title":"Bone Rep"},{"key":"10.1016\/j.bone.2020.115518_bb0110","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S8756-3282(00)00376-8","article-title":"Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women","volume":"27","author":"Boivin","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0115","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.bone.2003.08.004","article-title":"Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs","volume":"33","author":"Burr","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9290(69)90036-0","article-title":"The mechanical consequences of variation in the mineral content of bone","volume":"2","author":"Currey","year":"1969","journal-title":"J. Biomech."},{"key":"10.1016\/j.bone.2020.115518_bb0125","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years\u2019 experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.bone.2020.115518_bb0130","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment. The Fracture Intervention Trial Long-Term Extension (FLEX): a randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.bone.2020.115518_bb0135","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bone.2006.04.028","article-title":"Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate","volume":"39","author":"Allen","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00198-007-0451-8","article-title":"Changes in vertebral strength-density and energy absorption-density relationships following bisphosphonate treatment in beagle dogs","volume":"19","author":"Allen","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2020.115518_bb0145","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1172\/JCI116872","article-title":"The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates","volume":"92","author":"Balena","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2020.115518_bb0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S8756-3282(02)00923-7","article-title":"Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys","volume":"32","author":"Smith","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0155","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1359\/JBMR.040809","article-title":"Intermittent ibandronate preserves bone quality and bone strength in the lumbar spine after 16 months of treatment in the ovariectomized cynomolgus monkey","volume":"19","author":"M\u00fcller","year":"2004","journal-title":"J. Bone Miner. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2020.115518_bb0160","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.bone.2006.01.151","article-title":"Ibandronate: pharmacology and preclinical studies","volume":"38","author":"Russell","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0165","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1172\/JCI117901","article-title":"Comparison of alendronate and sodium fluoride effects on cancellous and cortical bone in minipigs","volume":"95","author":"LaFage","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2020.115518_bb0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF02672503","article-title":"Lifelong administration of high doses of ibandronate increases bone mass and maintains bone quality of lumbar vertebrae in rats","volume":"8","author":"Lalla","year":"1998","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2020.115518_bb0175","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1002\/art.22976","article-title":"The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids","volume":"56","author":"Balooch","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2020.115518_bb0180","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1359\/jbmr.071207","article-title":"Long-term protective effects of zolendronic acid on cancellous and cortical bone in the ovariectomized rat","volume":"23","author":"Gasser","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115518_bb0185","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00774-013-0543-9","article-title":"Risedronate improves bone architecture and strength faster than alendronate in ovariectomized rats on a low-calcium diet","volume":"32","author":"Yano","year":"2014","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2020.115518_bb0190","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1359\/jbmr.061011","article-title":"Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis","volume":"22","author":"Keaveny","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115518_bb0195","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1359\/jbmr.080805","article-title":"Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans","volume":"23","author":"Keaveny","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115518_bb0200","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00198-008-0750-8","article-title":"Assessment of vertebral fracture risk and therapeutic effects of alendronate in postmenopausal women using a quantitative computed tomography-based nonlinear finite element method","volume":"20","author":"Imai","year":"2009","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2020.115518_bb0205","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/jc.2008-1807","article-title":"Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis","volume":"94","author":"Leweicki","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2020.115518_bb0210","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures - results from the fracture intervention trial","volume":"280","author":"Cummings","year":"1998","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.bone.2020.115518_bb0215","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1359\/JBMR.050814","article-title":"Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate reduction in risk of nonvertebral fracture is not related to change in BMD","volume":"20","author":"Watts","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115518_bb0220","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0022-3565(25)12261-1","article-title":"Long-term safety of the aminobisphosphonate alendronate in adult dogs. I. General safety and biomechanical properties of bone","volume":"276","author":"Peter","year":"1996","journal-title":"J Pharm Exper Therap"},{"key":"10.1016\/j.bone.2020.115518_bb0225","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1359\/jbmr.070720","article-title":"Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment","volume":"22","author":"Allen","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115518_bb0230","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1359\/jbmr.2003.18.3.512","article-title":"Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra","volume":"18","author":"Komatsubara","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115518_bb0235","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1359\/JBMR.040126","article-title":"Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib","volume":"19","author":"Komatsubara","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115518_bb0240","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S8756-3282(01)00414-8","article-title":"Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles","volume":"28","author":"Mashiba","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0245","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","article-title":"Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib","volume":"15","author":"Mashiba","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115518_bb0250","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00223-008-9131-8","article-title":"Alendronate reduces bone turnover of ribs without significantly increasing microdamage accumulation in dogs following 3 years of daily treatment","volume":"82","author":"Allen","year":"2008","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2020.115518_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2013.01.016","article-title":"Effects of minodronate and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys","volume":"54","author":"Yamagami","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0260","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bone.2017.01.008","article-title":"Effects of suppressed bone remodeling by minodronate and alendronate in bone mass, microdamage accumulation, collagen crosslinks and bone mechanical properties in the lumbar vertebra of ovariectomized cynomolgus monkeys","volume":"97","author":"Mashiba","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0265","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bone.2016.05.001","article-title":"Minodronate ameliorates vertebral bone strength by increasing bone mineral density in 9-month treatment of ovariectomized cynomolgus monkeys","volume":"88","author":"Tanaka","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0270","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bone.2018.10.010","article-title":"Changes in bone matrix properties with aging","volume":"120","author":"Burr","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0275","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00223-002-2066-6","article-title":"Canine cancellous bone microarchitecture after one year of high-dose bisphosphonates","volume":"72","author":"Ding","year":"2003","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2020.115518_bb0280","first-page":"465","article-title":"Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties","volume":"22","author":"Day","year":"2004","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bone.2020.115518_bb0285","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/jor.20895","article-title":"Effects of 1 to 3 years\u2019 treatment with alendronate on mechanical properties of the femoral shaft in a canine model: implications for subtrochanteric femoral fracture risk","volume":"27","author":"Burr","year":"2009","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bone.2020.115518_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research","volume":"25","author":"Shane","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115518_bb0295","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.injury.2014.08.037","article-title":"Potential pathogenic mechanism for stress fractures of the bowed femoral shaft in the elderly: mechanical analysis by the CT-based finite element model","volume":"45","author":"Oh","year":"2014","journal-title":"Injury, Int J Care Injured"},{"key":"10.1016\/j.bone.2020.115518_bb0300","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11914-019-00525-x","article-title":"The role of lower-limb geometry in the pathophysiology of atypical femoral fracture","volume":"17","author":"Haider","year":"2019","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.bone.2020.115518_bb0305","doi-asserted-by":"crossref","first-page":"21072","DOI":"10.1038\/srep21072","article-title":"Intrinsic mechanical behavior of femoral cortical bone in young, osteoporotic and bisphosphonate-treated individuals in low- and high energy fracture conditions","volume":"6","author":"Zimmermann","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bone.2020.115518_bb0310","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jbmr.2401","article-title":"Effects of denosumab, alendronate, or denosumab following alendronate on bone turnover, calcium homeostasis, bone mass and bone strength in ovariectomized cynomolgus monkeys","volume":"30","author":"Kosteniuk","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115518_bb0325","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00198-004-1612-7","article-title":"Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing","volume":"15","author":"Bauss","year":"2004","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2020.115518_bb0330","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bone.2013.06.004","article-title":"Short-courses of dexamethasone abolish bisphosphonate-induced reductions in bone toughness","volume":"56","author":"Luo","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S8756-3282(01)00697-4","article-title":"Age-related changes in the collagen network and toughness of bone","volume":"31","author":"Wang","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0340","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00198-007-0533-7","article-title":"Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra","volume":"19","author":"Allen","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2020.115518_bb0345","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1138\/20090390","article-title":"Advanced glycation end-products and bone fractures","volume":"6","author":"Vashishth","year":"2009","journal-title":"IBMS Bonekey"},{"key":"10.1016\/j.bone.2020.115518_bb0350","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bone.2006.05.013","article-title":"Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae","volume":"39","author":"Viguet-Carrin","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0355","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00198-008-0754-4","article-title":"Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate","volume":"20","author":"Tang","year":"2009","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2020.115518_bb0360","doi-asserted-by":"crossref","first-page":"43399","DOI":"10.1038\/srep43399","article-title":"Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties","volume":"7","author":"Ma","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bone.2020.115518_bb0365","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1302\/2046-3758.610.BJR-2016-0321.R1","article-title":"The effect of long-term bisphosphonate therapy on trabecular bone strength and microcrack density","volume":"6","author":"Jin","year":"2017","journal-title":"Bone Joint Res"},{"key":"10.1016\/j.bone.2020.115518_bb0370","doi-asserted-by":"crossref","first-page":"152","DOI":"10.22203\/eCM.v028a12","article-title":"Effects of long-term alendronate treatment on bone mineralisation, resorption parameters, and biomechanics of single human vertebral trabeculae","volume":"28","author":"Krause","year":"2014","journal-title":"Europ Cells Mat"},{"key":"10.1016\/j.bone.2020.115518_bb0375","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bone.2014.10.010","article-title":"Duration-dependent effects of clinically relevant oral alendronate doses on cortical bone toughness in beagle dogs","volume":"71","author":"Burr","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0380","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1007\/s00198-016-3661-0","article-title":"Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonates","volume":"27","author":"Ward","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2020.115518_bb0385","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00198-018-4760-x","article-title":"Young\u2019s modulus and hardness of human trabecular bone with bisphosphonate treatment durations up to 20 years","volume":"30","author":"Peinkowski","year":"2019","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2020.115518_bb0390","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/jbmr.1719","article-title":"Incidence of atypical nontraumatic diaphyseal fractures of the femur","volume":"27","author":"Dell","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115518_bb0395","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bone.2015.08.002","article-title":"Alendronate treatment alters bone tissues at multiple structural levels in healthy canine cortical bone","volume":"81","author":"Acevedo","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0400","doi-asserted-by":"crossref","first-page":"8722","DOI":"10.1073\/pnas.1704460114","article-title":"Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance","volume":"114","author":"Lloyd","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bone.2020.115518_bb0405","first-page":"270","article-title":"Why bones bend but don\u2019t break","volume":"11","author":"Burr","year":"2011","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.bone.2020.115518_bb0410","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S8756-3282(01)00485-9","article-title":"Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women","volume":"29","author":"Roschger","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0415","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jbm.a.31576","article-title":"Fatigue strength of human cortical bone: age, physical, and material heterogeneity effects","volume":"86","author":"Zioupos","year":"2008","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.bone.2020.115518_bb0420","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/1097-4636(20000915)51:4<735::AID-JBM23>3.0.CO;2-G","article-title":"Microstructural heterogeneity and the fracture toughness of bone","volume":"51","author":"Phelps","year":"2000","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.bone.2020.115518_bb0425","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.bone.2008.01.022","article-title":"Cancellous bone lamellae strongly affect microcrack propagation and apparent mechanical properties: separation of patients with osteoporotic fracture from normal controls using a 2D nonlinear finite element method (biomechanical stereology)","volume":"42","author":"Wang","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0430","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1530\/EJE-11-0333","article-title":"Modifications of bone material properties in postmenopausal osteoporotic women long-term treated with alendronate","volume":"165","author":"Bala","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bone.2020.115518_bb0435","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/jbmr.1501","article-title":"Bone micromechanical properties are compromised during long-term alendronate therapy independently of mineralization","volume":"27","author":"Bala","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115518_bb0440","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.bone.2008.05.023","article-title":"Identification of material parameters based on Mohr-Coulomb failure criterion for bisphosphonate treated canine vertebral cancellous bone","volume":"43","author":"Wang","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0445","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover. A potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2020.115518_bb0450","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2265.2009.03581.x","article-title":"Unusual mid-shaft fractures during long-term bisphosphonate therapy","volume":"72","author":"Odvina","year":"2010","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.bone.2020.115518_bb0455","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.bone.2011.09.042","article-title":"Mechanical property and tissue mineral density differences among severely suppressed bone turnover (SSBT) patients, osteoporotic patients, and normal subjects","volume":"49","author":"Tjhia","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0460","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jbmr.1731","article-title":"Microindentation for in vivo measurement of bone tissue material properties in atypical femoral fracture patients and controls","volume":"28","author":"G\u00fcerri-Fern\u00e1ndez","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115518_bb0465","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bone.2015.03.021","article-title":"Comparison of cyclic and impact-based reference point indentation measurements in human cadaveric tibia","volume":"106","author":"Karim","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0470","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bone.2017.06.018","article-title":"Fracture during oral bisphosphonate therapy is associated with deteriorated bone material strength index","volume":"103","author":"Nogu\u00e9s","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0475","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jbmr.3590","article-title":"Cortical bone material strength inde3x and bone microarchitecture in postmenopausal women with atypical femoral fractures","volume":"34","author":"Popp","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115518_bb0480","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bone.2014.03.045","article-title":"The resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate","volume":"64","author":"Bajaj","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0485","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bone.2015.03.008","article-title":"Letter to the editor regarding Bajaj et al., The resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate. Bone 2014; 64:57\u201364","volume":"89","author":"Courtney","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0490","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bone.2015.03.007","article-title":"Letter to the editor. Response to Courtney et al.","volume":"89","author":"Bajaj","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.bone.2020.115518_bb0495","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bonr.2014.10.004","article-title":"The effect of osteoporosis treatments on fatigue properties of cortical bone tissue","volume":"2","author":"Brock","year":"2015","journal-title":"Bone Rep"},{"key":"10.1016\/j.bone.2020.115518_bb0500","doi-asserted-by":"crossref","DOI":"10.1115\/1.2838032","article-title":"The effect of strain rate on the mechanical properties of human cortical bone","volume":"130","author":"Hansen","year":"2008","journal-title":"J. Biomech. Eng."},{"key":"10.1016\/j.bone.2020.115518_bb0505","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1016\/j.jbiomech.2008.07.025","article-title":"Microcracking damage and the fracture process in relation to strain rate in human cortical bone tensile failure","volume":"412","author":"Zioupos","year":"2008","journal-title":"J. Biomech."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220302982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220302982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:55:50Z","timestamp":1757613350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328220302982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":99,"alternative-id":["S8756328220302982"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2020.115518","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fifty years of bisphosphonates: What are their mechanical effects on bone?","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2020.115518","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115518"}}